{
    "clinical_study": {
        "@rank": "65362", 
        "arm_group": [
            {
                "arm_group_label": "CC-plus uFSH", 
                "arm_group_type": "Active Comparator", 
                "description": "clomiphene citrate 50 mg tablets twice/day for  cycle days 3-7  plus daily IM injection of 37.5 IU HP uFSH for days 3-12"
            }, 
            {
                "arm_group_label": "Aromataze inhibitor plus uFSH", 
                "arm_group_type": "Experimental", 
                "description": "Aromataze inhibitor (litrezole )2.5 mg twice daily for cycle days 3-7 plus daily IM injection of  uFSH 37.5 IU for cycle days 3-12"
            }
        ], 
        "brief_summary": {
            "textblock": "Polycystic ovarian syndrome (PCOS) is a condition characterized by infertility, infrequent\n      periods and amenorrhea  or irregular bleeding plus anovulatory infertility. Clomid is the\n      standard first drug of treatment for ovulation induction. Ovulation and conception will\n      occur in  approximately 75 and 30 percent of cases respectively. Cases not ovulating in\n      response to doses of clomid up to 150 mg/day are known as clomid resistant PCOS."
        }, 
        "brief_title": "Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Polycystic Ovary Syndrome", 
            "Infertility"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Polycystic Ovary Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "To test whether CC co- treatment with chronic low dose HP uFSH versus  lirizole plus chronic\n      low dose HP uFSH  in CC resistant PCOS will yield comparable  results in terms of, ovulation\n      rate, lower follicle number, lower HP uFSH dose, better outcome in terms of pregnancy rates,\n      better cost-effectiveness ratio, lower multiple pregnancy rates, lower cycle cancellation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  CC resistant PCOS\n\n          -  Infertile\n\n          -  Females\n\n          -  Age 18-38\n\n        Exclusion Criteria:\n\n          -  Hyperprolactinaemia\n\n          -  Cushing syndrome\n\n          -  Adult onset adrenal hyperplasia\n\n          -  Age > 38\n\n          -  Other infertility factors in the couple than PCOS: male factor,tubal\n             factor,edometriosis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01793038", 
            "org_study_id": "Mific-3"
        }, 
        "intervention": [
            {
                "arm_group_label": "Aromataze inhibitor plus uFSH", 
                "description": "literozole  tablets 5 mg /day for days 3-7 plus intramuscular injections of  uFSH  37.5 IU/day for days 3-12", 
                "intervention_name": "Aromatase inhibitor (litrezole) plus uFSH arm", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "CC-plus uFSH", 
                "description": "clomiphene citrate 50 mg tablets twice /day for 5 days plus 37.5 IU uFSH IM injections  daily for 10 days", 
                "intervention_name": "clomiphene citrate-uFSH arm", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Clomiphene", 
                "Aromatase Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PCOS", 
            "clomiphene citrate resistant PCOS", 
            "Aromatase inhibitors"
        ], 
        "lastchanged_date": "March 5, 2013", 
        "location": {
            "contact": {
                "email": "meghanem87@gmail.com", 
                "last_name": "Mohamad E Ghanem, MD", 
                "phone": "00201223366955"
            }, 
            "facility": {
                "address": {
                    "city": "Mansoura", 
                    "country": "Egypt", 
                    "state": "Dekahlia"
                }, 
                "name": "Mansoura Integrated fertility center"
            }, 
            "investigator": {
                "last_name": "Mohamad E Ghanem, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clomiphene Citrate Plus HPuFSH Versus Letrozole Plus HPuFSH in Clomid Resistant Infertile PCOS Women", 
        "overall_contact": {
            "email": "meghanem87@gmail.com", 
            "last_name": "mohamad E GHanem, MD", 
            "phone": "00201223366955"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "percentage of ovulatory cycles per started and per completed cycles", 
            "measure": "ovulation rate", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "reference": [
            {
                "PMID": "21457973", 
                "citation": "Abdellah MS. Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet. 2011 Jun;113(3):218-21. doi: 10.1016/j.ijgo.2010.11.026. Epub 2011 Apr 1."
            }, 
            {
                "PMID": "19809318", 
                "citation": "Palomba S, Falbo A, Zullo F. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. Curr Opin Obstet Gynecol. 2009 Dec;21(6):465-73. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01793038"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mansoura Integrated Fertility Center", 
            "investigator_full_name": "Mohamad Elsaid Ghanem", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "endmetrial thickness at time of ovulation triggering", 
                "measure": "endometrial thickness", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "ongoing cycle pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }
        ], 
        "source": "Mansoura Integrated Fertility Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mansoura Integrated Fertility Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}